MDBH
name pending profile ingest
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2025
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | UBS Group AG | 55.75K | n/a | $180,906 | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 2 | Citadel Advisors ✦ | 24.67K | +96.3% | $81,158 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Morgan Stanley ✦ | 1 | 0.0% | $3 | 0.0% | Held | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 5 holders, 182.20K shares, $542,962 reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
Officer, Director, 10% owner · Co-Founder · 917 sh @ 1.93 · $1,770
Officer, Director, 10% owner · Co-Founder · 10.00K sh @ 1.99 · $19,900
Open-market sales (S)
Officer · 10.00K sh · $19,900
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology